12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Silence Therapeutics proposes private placement of convertible notes

Silence Therapeutics plc (LSE: SLN), London, U.K.
Business: Cancer, Renal, Ophthalmic
Date announced: 7/12/12
Type: Private placement of...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >